Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities

Summary

The primary objective of this study is to provide safety data for two different dosages of HydroLenz. Secondary objectives are to provide preliminary data to determine whether HydroLenz has the same effect in humans as it does in the porcine model; to confirm the reliability of methods for evaluating lens opacity; and, to acquire information that can be used to design the pivotal study.

Timeline

Start

2024-01-01

Primary completion

2025-01-01

Completion

2025-01-01

Outcome

Outcome not reported

Stopped (Business): “Funding Limitations”

Drugs

Indications

No indication recorded.